TABLE 1.

The demographic information of all samples

Sample no.	Group	Average Agea	Gender (M/F)	Age (y)	Delay of Collection after Death (h)	Weight of Retina (g)	Weight of RPE/Choroid (g)	Eye Disease History	Cause of Death
1	Young age group	16.4 ± 3.6	M	17	14	0.1547	0.0953	No	Heart failure
2			F	22	21	0.0879	0.1208	No	Respiratory collapse
3			F	12	16	0.1149	0.1223	No	Multiple sclerosis
4			F	15	22	0.0873	0.1006	No	Anoxic brain injury
5			M	16	22	0.1149	0.1223	No	Blunt force head trauma
6	Middle age group	38.2 ± 6.2	M	36	26	0.0917	0.0867	No	Respiratory failure
7			M	38	26	0.0846	0.0775	No	Aspiration pneumonia
8			M	49	13	0.1157	0.1181	No	Respiratory arrest
9			M	39	16	0.1099	0.1090	No	Myocardial infarction
10			M	37	6	0.0799	0.0990	No	End-stage renal failure
11			M	30	8	0.1056	0.0976	No	Congestive heart failure
12	Old age group	74.0 ± 3.4	M	77	15	0.1164	0.1363	No	Trauma
13			F	78	23	0.1332	0.0992	No	Cerebrovascular accident
14			M	72	20	0.1550	0.1089	No	Cerebrovascular accident
15			F	70	7	0.1242	0.1378	No	Cerebrovascular accident
16			F	73	17	0.1542	0.1678	No	Amyotrophic lateral sclerosis
17	Age-matched AMD group	77.2 ± 6.4	M	78	23	0.1538	0.1375	AMD	Cancer
18			F	70	23	0.1123	0.1462	AMD	Myocardial infarction
19			M	75	22	0.1557	0.1562	AMD	Lymphoma
20			M	73	17	0.0947	0.1008	AMD	Respiratory failure
21			M	81	8	0.1357	0.1313	AMDb	Circulatory collapse
22			F	84	22	0.2557	0.2562	AMD	Renal failure
23			F	87	18	0.1671	0.1395	AMDb	Respiratory failure, breast cancer
24			M	70	8	0.1222	0.0722	AMD	Circulatory collapse

^aAverage ± SD.

^bThese AMD patients had exudative AMD. All other AMD patients had early to intermediate dry AMD with drusen and pigmentary changes but no history of geographic atrophy or exudative disease.